Drug resistance to EGFR inhibitors in lung cancer

O Tetsu, MJ Hangauer, J Phuchareon, DW Eisele… - Chemotherapy, 2016 - karger.com
… types based on microscopic features: small-cell lung cancer (… EGFR TKI-resistant cells during
EGFR TKI treatment may … primary drug resistance to a large number of cancer cell lines by …

Drug Tolerance to EGFR Tyrosine Kinase Inhibitors in Lung Cancers with EGFR Mutations

K Suda, T Mitsudomi - Cells, 2021 - mdpi.com
… studies to generally describe the features, potential origins, … an optimal treatment for
EGFR-mutated lung cancer will require … that each EGFR-mutated lung cancer cell line may employ …

Efficacy of the CDK7 inhibitor on EMT-associated resistance to 3rd generation EGFR-TKIs in non-small cell lung cancer cell lines

W Ji, YJ Choi, MH Kang, KJ Sung, DH Kim, S Jung… - Cells, 2020 - mdpi.com
… acquired resistance to 3rd generation EGFR inhibitors is critical … expressed in resistant cell
lines generated by treatment with … cells can have similar characteristics to the parental cells in …

Novel third-generation EGFR tyrosine kinase inhibitors and strategies to overcome therapeutic resistance in lung cancer

A Murtuza, A Bulbul, JP Shen, P Keshavarzian… - Cancer Research, 2019 - AACR
… experience with EGFR inhibitors in lung cancer, drug resistance, … in the first-line treatment
of EGFR-mutant lung cancer (11, 12). … Early work with a gefitinib-sensitive lung cancer cell line

[HTML][HTML] … of epithelial-mesenchymal transition intermediate/hybrid phenotypes associated to resistance to EGFR inhibitors in non-small cell lung cancer cell lines

V Fustaino, D Presutti, T Colombo, B Cardinali… - Oncotarget, 2017 - ncbi.nlm.nih.gov
… Indeed, EMT features in the erlotinib-resistant cell lines were … positive cells resulted by the
comparison of cell lines treated … a 500 μm wide cell-free gap (wound) was generated. The dish …

EPHA2 blockade overcomes acquired resistance to EGFR kinase inhibitors in lung cancer

KR Amato, S Wang, L Tan, AK Hastings, W Song… - Cancer research, 2016 - AACR
… target for the treatment of EGFR TKI-resistant lung cancer. In … -resistant and two
erlotinib-sensitive lung cancer cell lines. Both … -27 on cells resistant to the third-generation EGFR

Intrinsic Resistance to EGFR-Tyrosine Kinase Inhibitors in EGFR-Mutant Non-Small Cell Lung Cancer: Differences and Similarities with Acquired Resistance

E Santoni-Rugiu, LC Melchior, EM Urbanska… - Cancers, 2019 - mdpi.com
… Given these properties, 1G and 2G EGFR-TKIs for several … cases treated with this drug as
second line become resistant within … investigations in NSCLC cell lines and animal models that …

[HTML][HTML] Combination of gefitinib and pemetrexed prevents the acquisition of TKI resistance in NSCLC cell lines carrying EGFR-activating mutation

S La Monica, D Madeddu, M Tiseo, V Vivo… - Journal of Thoracic …, 2016 - Elsevier
… gene (EGFR)-mutated non–small cell lung cancer (NSCLC). … process in which cells lose
their epithelial features and acquire … that EGFR T790M mutation emerged only in tumors treated

Targeting FGFR overcomes EMT-mediated resistance in EGFR mutant non-small cell lung cancer

S Raoof, IJ Mulford, H Frisco-Cabanos, V Nangia… - Oncogene, 2019 - nature.com
features and suggest that dual EGFR + FGFR inhibition may be … to re-sensitize mesenchymal
cell lines to EGFR inhibition, we … EGFR-mutant NSCLC cells to EGFR inhibitors, we treated

EMT: A mechanism for escape from EGFR-targeted therapy in lung cancer

E Tulchinsky, O Demidov, M Kriajevska… - … )-Reviews on Cancer, 2019 - Elsevier
lung cancer treatment results in enormous number of saved lives. Clinical development of
EGFR inhibitors … ; and mesenchymal cell lines were more resistant to the compounds inhibiting